Model designed to fill need for soluble amyloid beta oligomer reference standards in bioanalytical assays…
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…
Supports the company’s plans to build a biotherapeutics cultivation and manufacturing site in Cumberland, Maryland CUMBERLAND,…
New York, NY, and Tel Aviv, ISRAEL, Aug. 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
The addition of a U.S. site will allow SciSparc to accelerate trial recruitment and further…
–Company Continues to Execute on Core Business Model While Enhancing Value Proposition and Pipeline with…
Media, Pennsylvania–(Newsfile Corp. – August 1, 2022) – Splinterlands, the worldwide leading blockchain game, has…
Riyadh, Saudi Arabia, Aug 1, 2022 – (ACN Newswire) – After successful 13 editions of…
North Miami, Florida , Aug 1, 2022 – (ACN Newswire) – The acclaimed annual telehealth…
WASHINGTON–(BUSINESS WIRE)–#FightWorldHunger–GrainPro announced today that its second quarter sales were $4.3 million, a 38% increase…
Social Responsibility Score (SRS) brand level diagnostic & tracker is now capturing consumer perceptions of…
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., Aug….
RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
GreenLight Woburn lab 2 GreenLight’s messenger RNA production process is transferable to large-scale equipment and…
Updates on Recent Transaction and Business will be Provided OXNARD, Calif., Aug. 01, 2022 (GLOBE…
ProLectin-M, a new class of oral antiviral drug BOSTON, MASSACHUSETTS, Aug. 01, 2022 (GLOBE NEWSWIRE)…
HAMILTON, BERMUDA , Aug. 01, 2022 (GLOBE NEWSWIRE) — Enrollment to be continued to 160…
Submission has been granted priority review and given a target regulatory decision date of November…
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified…
Fort Lee, NJ, Aug. 01, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (Nasdaq: NVCT) (“Nuvectis”…